Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
Louis
Elie
E
Fédération Neurologique Mazarin, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Keime-Guibert
Florence
F
Delattre
Jean-Yves
JY
Sanson
Marc
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D003337:Corpus Callosum / Q000473:pathology; D005625:Frontal Lobe / Q000473:pathology; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008297:Male; D018302:Neoplasms, Neuroepithelial / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D009836:Oligodendroglia / Q000473:pathology*; D010296:Parietal Lobe / Q000473:pathology; D011344:Procarbazine / Q000008:administration & dosage; D012074:Remission Induction; D012640:Seizures / Q000209:etiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D008130:Lomustine